Last reviewed · How we verify

Basic buccal procedure + Long acting local

University of California, San Francisco · Phase 3 active Small molecule

A buccal procedure combined with long-acting local anesthetic delivery to provide sustained pain relief or therapeutic effect in the oral cavity.

A buccal procedure combined with long-acting local anesthetic delivery to provide sustained pain relief or therapeutic effect in the oral cavity. Used for Buccal pain management or local therapeutic delivery (specific indication unclear from description).

At a glance

Generic nameBasic buccal procedure + Long acting local
SponsorUniversity of California, San Francisco
ModalitySmall molecule
Therapeutic areaPain Management / Oral/Dental
PhasePhase 3

Mechanism of action

This appears to be a procedural intervention rather than a traditional pharmaceutical drug, combining a basic buccal (cheek/mouth) procedure with a long-acting local anesthetic formulation to extend the duration of local pain control or therapeutic benefit. The long-acting component likely uses a sustained-release or depot formulation of a local anesthetic agent administered at the buccal site.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: